Back

Anticoagulation control and all-cause death in patients with operated valvular heart disease with and without atrial fibrillation receiving vitamin K antagonists

1 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Epidemiology, pathophysiology and particular aspects of valve disease Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Associate Professor Daniele Pastori

Sapienza University of Rome, Rome (Italy)

9 More presentations in this session

Presentation thumbnail
Doctor H. Zhang (Beijing, CN)
Abstract
Presentation thumbnail
Doctor A. El Ghamrawy (Almahalla Alkobra, EG)
Abstract Slides
Presentation thumbnail
Associate Professor S. Myerson (Oxford, GB)
Abstract Slides
Presentation thumbnail
Doctor Z. meng (Beijing, CN)
Abstract
Presentation thumbnail
Mr M. Ezhov (Moscow, RU)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - Epidemiology, pathophysiology and particular aspects of valve disease

The Event

Event poster

ESC Congress 2019

1 September 2019 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
27 August 2021
thumbnail
Congress Presentation
Direct oral anticoagulants compared to vitamin K-antagonists in patients with left ventricular thrombus
27 August 2022
thumbnail
Congress Presentation
Association between warfarin and direct oral anticoagulants users and risk of mortality: cohort studies in England and Hong Kong
1 September 2024
thumbnail
Congress Presentation
Undertreated hypertension: a major factor in intracranial haemorrhage-related mortality in anticoagulated patients with atrial fibrillation
1 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources